Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Treatment for Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03235557
What this trial is testing

CyberKnife for Prostate Cancer Patients Aged 70 y or More

Who this might be right for
Prostate Cancer
Centre Francois Baclesse, Luxembourg 150
Testing effectiveness (Phase 2)Ended earlyNCT00048893
What this trial is testing

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05003752
What this trial is testing

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRadiation Toxicity
German Oncology Center, Cyprus 40
Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Not applicableActive Not RecruitingNCT03827616
What this trial is testing

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms
Tatarstan Cancer Center 400
Large-scale testing (Phase 3)Ended earlyNCT00104936
What this trial is testing

Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 9
Not applicableUnknownNCT00385164
What this trial is testing

The Utility of FDG-PET for Radiation Treatment in NSCLC

Who this might be right for
Lung NeoplasmsPositron Emission Tomography
AHS Cancer Control Alberta 50
Early research (Phase 1)Ended earlyNCT01334099
What this trial is testing

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
University Health Network, Toronto 6
Testing effectiveness (Phase 2)Study completedNCT00014599
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Who this might be right for
Vulvar Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Not applicableEnrolling By InvitationNCT06311877
What this trial is testing

Effects of Flavor Modification for Management of Radiation Induced Dysgeusia

Who this might be right for
Dysgeusia
University of South Florida 30
Not applicableEnded earlyNCT02614157
What this trial is testing

Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 51
Very early researchEnded earlyNCT02070393
What this trial is testing

Breast-Sparing Proton Therapy for Hodgkin's Disease

Who this might be right for
Hodgkins Disease
Indiana University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing

Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69
Large-scale testing (Phase 3)Looking for participantsNCT06214195
What this trial is testing

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Who this might be right for
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital 276
Testing effectiveness (Phase 2)Study completedNCT00004172
What this trial is testing

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT07178301
What this trial is testing

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Northwestern University 100
Testing effectiveness (Phase 2)UnknownNCT02545751
What this trial is testing

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerStereotactic Body Radiation Therapy+1 more
Hangzhou Cancer Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00923195
What this trial is testing

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Early research (Phase 1)Looking for participantsNCT06800339
What this trial is testing

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Maryland, Baltimore 18
Not applicableStudy completedNCT01988272
What this trial is testing

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
University of Michigan 33
Next Page